1. Home
  2. LIVE vs BTAI Comparison

LIVE vs BTAI Comparison

Compare LIVE & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIVE
  • BTAI
  • Stock Information
  • Founded
  • LIVE 1968
  • BTAI 2017
  • Country
  • LIVE United States
  • BTAI United States
  • Employees
  • LIVE N/A
  • BTAI N/A
  • Industry
  • LIVE Other Specialty Stores
  • BTAI Biotechnology: Pharmaceutical Preparations
  • Sector
  • LIVE Consumer Discretionary
  • BTAI Health Care
  • Exchange
  • LIVE Nasdaq
  • BTAI Nasdaq
  • Market Cap
  • LIVE 55.6M
  • BTAI 52.7M
  • IPO Year
  • LIVE N/A
  • BTAI 2018
  • Fundamental
  • Price
  • LIVE $17.67
  • BTAI $2.66
  • Analyst Decision
  • LIVE
  • BTAI Buy
  • Analyst Count
  • LIVE 0
  • BTAI 5
  • Target Price
  • LIVE N/A
  • BTAI $32.80
  • AVG Volume (30 Days)
  • LIVE 17.0K
  • BTAI 1.5M
  • Earning Date
  • LIVE 08-07-2025
  • BTAI 11-13-2025
  • Dividend Yield
  • LIVE N/A
  • BTAI N/A
  • EPS Growth
  • LIVE N/A
  • BTAI N/A
  • EPS
  • LIVE 0.46
  • BTAI N/A
  • Revenue
  • LIVE $443,794,000.00
  • BTAI $868,000.00
  • Revenue This Year
  • LIVE N/A
  • BTAI N/A
  • Revenue Next Year
  • LIVE N/A
  • BTAI $614.78
  • P/E Ratio
  • LIVE $38.09
  • BTAI N/A
  • Revenue Growth
  • LIVE N/A
  • BTAI N/A
  • 52 Week Low
  • LIVE $6.25
  • BTAI $1.17
  • 52 Week High
  • LIVE $25.88
  • BTAI $13.28
  • Technical
  • Relative Strength Index (RSI)
  • LIVE N/A
  • BTAI 38.51
  • Support Level
  • LIVE N/A
  • BTAI $2.42
  • Resistance Level
  • LIVE N/A
  • BTAI $2.70
  • Average True Range (ATR)
  • LIVE 0.00
  • BTAI 0.19
  • MACD
  • LIVE 0.00
  • BTAI 0.00
  • Stochastic Oscillator
  • LIVE 0.00
  • BTAI 12.17

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: